Position in QNCX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$6,658
-$349,185 QoQ
Shares Held
330
-37.9% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in QNCX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,658 | 65,931 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $355,843 | 106,222 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $105,470 | 64,706 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $127,861 | 77,492 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $103,064 | 77,492 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $94,479 | 50,524 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,401 | 34,023 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $25,516 | 34,023 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $36,123 | 34,079 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $46,050 | 43,858 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $49,120 | 43,858 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $66,005 | 43,858 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $63,057 | 40,422 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $21,491 | 33,739 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $60,832 | 45,739 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $101,733 | 45,826 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,215,145 | 196,308 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,442,738 | 193,561 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $18,400,559 | 200,748 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,871,042 | 205,114 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,108,344 | 169,535 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,982,341 | 179,350 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $9,038,000 | 180,760 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,103,794 | 175,028 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $5,796,436 | 127,087 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||